No impact to previous guidance.In some ways this is positive as Phase 3 trials cost a lot to run.Csl can concentrate on making the AstraZeneca/Oxford vaccine instead.
Ann: Update on UQ-CSL v451 COVID-19 Vaccine, page-2
-
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$307.92 |
Change
-0.330(0.11%) |
Mkt cap ! $148.7B | |||
| Open | High | Low | Value | Volume |
| $307.60 | $308.47 | $306.22 | $23.25M | 75.63K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 43 | $307.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $307.92 | 59 | 6 |
View Market Depth
| Last trade - 11.28am 21/08/2024 (20 minute delay) ? |
| CSL (ASX) Chart |